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Background: Previous research has shown variations in quality of care and patient outcomes under different
primary care models. The objective of this study was to use previously validated, evidence-based performance
indicators to measure quality of asthma care over time and to compare quality of care between different primary
care models.
Methods: Data were obtained for years 2006 to 2010 from the Ontario Asthma Surveillance Information System,
which uses health administrative databases to track individuals with asthma living in the province of Ontario,
Canada. Individuals with asthma (n=1,813,922) were divided into groups based on the practice model of their
primary care provider (i.e., fee-for-service, blended fee-for-service, blended capitation). Quality of asthma care was
measured using six validated, evidence-based asthma care performance indicators.
Results: All of the asthma performance indicators improved over time within each of the primary care models.
Compared to the traditional fee-for-service model, the blended fee-for-service and blended capitation models had
higher use of spirometry for asthma diagnosis and monitoring, higher rates of inhaled corticosteroid prescription,
and lower outpatient claims. Emergency department visits were lowest in the blended fee-for-service group.
Conclusions: Quality of asthma care improved over time within each of the primary care models. However, the
amount by which they improved differed between the models. The newer primary care models (i.e., blended
fee-for-service, blended capitation) appear to provide better quality of asthma care compared to the traditional
fee-for-service model.
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Common worldwide challenges to the delivery of primary
care have included limited time spent with patients, min-
imal funding and physician shortages. Primary care sys-
tems have attempted to alleviate the burden of some of
these issues, and as a result different primary models have
been implemented around the world, leading to an in-
creased number of group-based practices and changes to
remuneration. Recent primary care changes in Ontario,
Canada have moved away from the traditional fee-for-
service model, towards models that emphasize patient
enrolment and provision of packaged services, such as* Correspondence: teresa.to@sickkids.ca
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models. These models are thought to provide a more
comprehensive approach to patient care. Since this transi-
tion, much research has focused on structural aspects of
the new models, such as patient enrolment or number of
services provided. More recently, there has been an inter-
est in the quality of care provided by these models. Russell
et al. examined performance indicators specific to dia-
betes, congestive heart failure and coronary artery disease
and found that physicians under salaried models provided
superior quality of care to patients with those conditions
[1]. Liddy et al. also found quality of diabetes treatment to
be better in salaried models, whereas quality of preventa-
tive measures, such as smoking cessation, was better
among blended capitation models [2].is an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ing the quality of asthma care. For example, the Primary
Care Asthma Program has been implemented in over
one-hundred primary care locations with the aim of pro-
viding tools to guide practitioners and patients in more
effectively managing asthma [3-5]. However, despite
these recent endeavours to improve the future quality of
asthma care, little is known about the current quality of
asthma care in Ontario, particularly among different pri-
mary care models. As Ontario is still in the process of a
primary care change, a better understanding of quality
of care among primary care models for particular condi-
tions typically cared for at the primary care level, such
as asthma, are of interest. The objective of this study
was to use previously validated, evidence-based perform-
ance indicators to measure quality of asthma care over
time and to compare quality of care between different
primary care models.
Methods
Study population
The Ontario Asthma Surveillance Information System
(http://www.sickkids.ca/Research/OASIS) is a population-
based, longitudinal surveillance system that identifies and
tracks individuals living with asthma in Ontario, Canada
using four health administrative databases housed at
the Institute for Clinical Evaluative Sciences (details in
Additional file 1). Linkage of datasets using an encrypted
version of the unique health insurance number given to all
Ontario residents allows for examination of individuals’
complete health services use across health care domains.
Health services claims identified from the databases from
fiscal year 2006 (April 1, 2006 - March 31, 2007) to fiscal
year 2010 (April 1, 2010 - March 31, 2011) were included.
A previously validated case definition of asthma was used
to identify individuals with asthma, and included those
who have had at least two primary care visit claims for
asthma in two consecutive years and/or at least one
hospitalization for asthma [6,7]. This definition has been
shown to have 89% sensitivity and 72% specificity in chil-
dren (under 18 years old) and 83.8% sensitivity and 76.5%
specificity in adults [6,7].
Outcome measures – asthma performance indicators
Quality of primary care was measured using six vali-
dated, evidence-based asthma performance indicators
from the linked databases described above [8]. Outcome
measures included four process-related indicators: spir-
ometry for diagnosis, spirometry for monitoring, reliever
and controller medication prescription; and two outcome-
related indicators: primary care visits and emergency de-
partment visits for asthma.
Spirometry for diagnosis was calculated as the percent
of cases in which testing was performed in those ≥7yearsof age within 3.5 years of the presumed asthma diagnosis
date (1 year prior and 2.5 years post asthma diagnosis)
[9]. Spirometry for monitoring was calculated as the per-
cent of cases in which testing was performed in those ≥7
years of age in the past 12 months. It has been suggested
that pulmonary function measures should be followed
over the patient’s lifetime to detect a decline of lung
function and to track the rate of decline longitudinally.
Medication reliever and controller prescription indica-
tors were calculated as the percent of individuals with
asthma who were prescribed, respectively, short-acting
β2-agonists (SABA) and inhaled corticosteroids (ICS) in
the previous 12 months. It should be noted that while
ICS remains the first-line controller therapy for all ages
as recommended in most asthma management guide-
lines, physicians may adjust the ICS dose or discontinue
ICS depending on levels of asthma control. Canadian
Guidelines suggests that very mild, intermittent asthma
may be treated with SABA as needed [10]. Medication
data was only available for persons >65 years of age
(12.1% of the asthma population in this study) and
others eligible for the Ontario Drug Benefits Program,
which includes those living in long-term care homes,
those enrolled in home care programs, those with high
drug costs relative to their income, and those receiving so-
cial assistance. Thus, findings of medication use should be
interpreted with caution.
While many physicians diagnose individuals as having
asthma based on the symptoms they present, such as
wheezing, shortness of breath or cough, asthma guide-
lines recommend that asthma be diagnosed using spir-
ometry. Once diagnosed, asthma is to be controlled with
daily (versus intermittent) ICS use, thus we considered
higher rates of spirometry and ICU prescription to re-
flect higher quality of care [11]. In contrast, lower
SABA prescription rates were generally considered to
reflect better asthma control and consequently higher
quality of care. The number of canisters filled was cal-
culated by total amount paid divided by unit cost of
the respective medication. Less than or equal to 4 can-
isters per patient per year was thought to reflect better
asthma control and ≥13 canisters per patient per year
was thought to reflect poorer asthma control [12,13]. It
should be noted that low use of SABA may also reflect
suboptimal medical care or patient adherence in some
cases, thus SABA findings should be interpreted with
caution.
Primary care visits for asthma and emergency depart-
ment visits for asthma were calculated per 100 patients
with asthma in the past 12 months.
International Classification of Diseases (ICD) codes
were used in the creation of the study population and to
identify asthma health services use; specifically, ICD-9
(493) and ICD-10 (J45, J46) codes were used.
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The Ontario Ministry of Health and Long-Term Care
(MOHLTC) has set criteria for each type of primary care
practice model used by family medicine physicians in
the delivery of care [2]. Physicians are remunerated either
by fee-for-service or by one of the patient enrolment
models: blended fee-for-service, blended capitation, or sal-
ary. Fee-for-service billing involves payment for every item
or unit of care that physicians provide for their patients;
physicians remunerated by fee-for-service may practice in-
dependently (solo) or be affiliated with a group (non-solo).
The blended fee-for-service model remunerates physicians
primarily through fee-for-service, but also includes incen-
tives and bonuses for services to enrolled patients. The
blended capitation model remunerates physicians based
on number of enrolled patients, and on providing a basket
of services to enrolled patients based on age and sex. Each
additional service would be paid for by fee-for-service.
Physicians working under the salaried model are remuner-
ated based on the number of physicians within a group
that provide services to a specific community. The defini-
tions of practice models used came from the MOHLTC,
and have been used previously by others [14]. Specific de-
tails can be found on the Health Force Ontario website:
www.healthforceontario.ca/en/Home/Physicians/Training_|_
Practising_in_Ontario/Physician_Roles/Family_Practice_
Models/Family_Practice_Compensation_Models. These
categories are mutually exclusive; physicians can only be
listed in one model at any given time. All models were in
effect for the entirety of the study period.
Physician demographic data came from the Institute
for Clinical Evaluative Sciences (ICES) Physician Data-
base. Fee-for-service practitioners were identified using
Ontario Health Insurance Plan data and the ICES Phys-
ician Database, whereas physicians in the blended fee-for-
service and blended capitation models were identified
using Client Agency Program Enrolment data tables. Less
than 1% of the study population failed to be linked to a
practice model. Lack of access to community health centre
data (one group within the salaried model) prevented the
inclusion of the 73 community health centres in Ontario,
which serviced approximately 4% of the population. Due
to small sample sizes and a unique, potentially biasing
geographic location, the Rural Northern Physician Group
(the other group within the salaried model) was not in-
cluded in this study. As community health centres and
Rural Northern Physicians Groups are the only groups in
Ontario under the salaried physician model, this study
does not include data on the salaried model.
Covariates and potential confounders
Potential confounding factors were adjusted for in a multi-
variable analysis [15]. Patient factors included sex, age
group, socioeconomic status (inferred from neighbourhoodincome, as derived from postal codes and census data)
and rurality (determined using postal code and based on
living in a municipality with fewer than 10,000 people).
Since some patients with asthma may also have chronic
obstructive pulmonary disease (COPD) that may influence
disease management [16], co-diagnosis of COPD was in-
cluded as a covariate in the multivariable analysis. Individ-
uals were defined as having COPD if they were ≥35 years
of age and had at least one COPD hospitalization and/or
one COPD ambulatory care claim (85% sensitivity & 78%
specificity) [17]. Physician factors included sex, age, years
practicing medicine and whether or not training occurred
in Canada. Volume of registered asthma patients was also
considered.
Statistical analysis
A retrospective population-based cross-sectional study
design was used. Six asthma indicator trends over time
were described overall and stratified by primary care
practice models. The equivalence test [18] was used to
evaluate differences between groups for each of the pa-
tient and physician characteristics. All variables listed in
Table 1 were included in the multivariable regression
analysis. Two-level Poisson regression models with GEE
(Generalized Estimating Equations) were used to ac-
count for clustering of patients within primary care
models as well as individuals’ variation across study
years. We modeled the effects of primary care models
while adjusting for over-dispersion (details in Additional
file 2), and physician and patient characteristics on each
of the asthma performance indicators. Poisson regression
risk ratios were presented with 95% confidence intervals.
For comparisons, fee-for-service physicians were used as
the reference group because they reflected the original
model of health care remuneration used in Ontario. Ana-
lyses were performed using SAS version 9.2 [19].
Ethics statement
The study was approved by the institutional review boards
at The Hospital for Sick Children, Toronto, Ontario. For
the purposes of this research informed consent was not
required. The Institute for Clinical Evaluative Sciences
(ICES) is named as a prescribed entity in Section 45 of the
Personal Health Information Protection Act (PHIPA –
Regulation 329/04, Section 18). Under this designation,
ICES can receive and use health information without con-
sent for purposes of analysis and compiling statistical in-
formation about the Ontario health care system.
Results
Study population
Patient and physician characteristics for 2006 and 2010
are shown in Table 1. The majority of patients with asthma
were managed by blended fee-for-service physicians.
Table 1 Characteristics of patient population and physician by practice models
Overall Fee-for-service Blended fee-for-service Blended capitation
Number % Number % Number % Number %
2006
Patient characteristics
Number of asthma patients 1675282 292222 17.4 1089808 65.1 293252 17.5
Female 890927 53.2 143906 49.2 585260 53.7 161761 55.2
Age groups (years)
0-4 96542 5.8 33587 11.5 50034 4.6 12921 4.4
5-14 368576 22.0 76955 26.3 232332 21.3 59289 20.2
15-64 1016084 60.7 151812 52.0 680563 62.4 183709 62.6
65+ 194080 11.6 29868 10.2 126879 11.6 37333 12.7
Means ± SD 32.8 ± 22.8 28.9 ± 23.3 33.5 ± 22.6 34.2 ± 22.9
SES by income quintiles
Quintile 1 - Low 336646 20.1 67381 23.1 213563 19.6 55702 19.0
Quintile 2 335756 20.0 59583 20.4 217530 20.0 58643 20.0
Quintile 3 335221 20.0 55365 18.9 222161 20.4 57695 19.7
Quintile 4 336365 20.1 54480 18.6 220976 20.3 60909 20.8
Quintile 5 - High 325477 19.4 54038 18.5 212220 19.5 59219 20.2
Missing 5817 0.3 1375 0.5 3358 0.3 1084 0.4
Rural residence 174688 10.4 24219 8.3 90771 8.3 59698 20.4
Physician characteristics
Number of physicians 11700 5526 47.2 4603 39.3 1571 13.4
Female 4105 35.1 1816 32.9 1710 37.1 579 36.9
Mean age ± SD 49.6 ± 12.4 50.8 ± 14.4 48.9 ± 10.4 47.8 ± 9.9
Mean years in practice ± SD 23.7 ± 11.9 24.7 ± 13.2 23.3 ± 10.7 21.9 ± 10.3
Trained in Canada 8154 69.7 3444 62.3 3371 73.2 1339 85.2
Number of asthma patients on roster
≤200 2570 22.0 1792 32.4 570 12.4 208 13.2
201-375 2983 25.5 1114 20.2 1352 29.4 517 32.9
≥376 6147 52.5 2620 47.4 2681 58.2 846 53.9
2010
Patient characteristics
Number of asthma patients 1813922 190656 10.5 844836 46.6 778430 42.9
Female 961173 53.0 90427 47.4 443166 52.5 427580 54.9
Age groups (years)
0-4 77534 4.3 20852 10.9 33098 3.9 23584 3.0
5-14 322417 17.8 48422 25.4 152475 18.0 121520 15.6
15-64 1193641 65.8 102771 53.9 559602 66.2 531268 68.2
65+ 220330 12.1 18611 9.8 99661 11.8 102058 13.1
Means ± SD 34.5 ± 22.5 28.6 ± 23.1 34.5 ± 22.3 35.9 ± 22.4
SES by income quintiles
Quintile 1 - low 347895 19.2 41894 22.0 169429 20.1 136572 17.5
Quintile 2 356347 19.6 37922 19.9 171875 20.3 146550 18.8
Quintile 3 365799 20.2 36844 19.3 176756 20.9 152199 19.6
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Table 1 Characteristics of patient population and physician by practice models (Continued)
Quintile 4 380224 21.0 37315 19.6 175459 20.8 167450 21.5
Quintile 5 - high 357418 19.7 35785 18.8 148943 17.6 172690 22.2
Missing 6239 0.3 896 0.5 2374 0.3 2969 0.4
Rural residence 181703 10.0 12740 6.7 41459 4.9 127504 16.4
Physician characteristics
Number of Physicians 12418 5112 41.2 3487 28.1 3819 30.8
Female 4854 39.1 1886 36.9 1377 39.5 1591 41.7
Mean age ± SD 50.6 ± 12.5 51.2 ± 14.4 51.3 ± 11.3 49.2 ± 10.6
Mean years in practice ± SD 24.7 ± 12.4 25.1 ± 13.7 25.6 ± 11.6 23.2 ± 11.2
Trained in Canada 8679 69.9 3305 64.7 2187 62.7 3187 83.5
Number of asthma patients on roster
≤200 2695 21.7 1516 29.7 576 16.5 603 15.8
201-375 3451 27.8 1043 20.4 963 27.6 1445 37.8
≥376 6272 50.5 2553 49.9 1948 55.9 1771 46.4
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models for sex, age, and rural residence. The fee-for-
service model had a smaller percentage of female pa-
tients and a larger percentage of younger patients.
Detailed data by narrower age groups are provided in
Additional file 3. The blended capitation model con-
sisted of more patients living in rural areas. With regard
to physician characteristics, the blended capitation
model contained more physicians who were trained in
Canada. The blended fee-for-service and blended capita-
tion models were more likely to have higher number of
asthma patients on their roster than fee-for-service phy-
sicians. The proportions of female physicians did not
differ across practice models.
Overall trends of asthma care measured by asthma
performance indicators
As seen in Table 2, between 2006 and 2010 there was an
overall and gradual increase in the use of spirometry for
diagnosis and monitoring of patients with asthma. How-
ever, despite this increase in use, in 2010 only half
(52.5%) of all asthma diagnoses were confirmed by
spirometry, and only 19.1% of asthma patients were
monitored annually with spirometry. Overall prescrip-
tions for ICS increased and prescriptions for SABA
remained relatively stable over the study period. The
percentage of patients being prescribed ≤4 SABA can-
isters per year increased over time, whereas the per-
centage of patients being prescribed 13 to 20 and >20
canisters per year decreased over time. Asthma primary
care and emergency department visits decreased over
time. Primary care and emergency department visits
also decreased over time for non-asthma related issues,
but not to the same extent as the decline in asthma-
specific visits.Crude comparisons of asthma performance indicators by
primary care practice models
Evaluation of asthma performance indicators demon-
strated marked differences over time and among primary
care models (Figures 1, 2, 3, 4, 5 and 6). Use of spirom-
etry for asthma diagnosis and monitoring increased over
time in all groups; however the increase in the fee-for-
service group was the smallest over time for both diagno-
sis and monitoring (Figures 1 and 2). Use of spirometry
for both diagnosis and monitoring was highest over time
in the blended capitation group and lowest over time in
the fee-for-service group. ICS prescription appears to have
increased in the blended-fee-for-service group, while
remaining about the same in the other two groups over
time; ICS prescription is consistently lower in the fee-for-
service group (Figure 3). SABA prescriptions decreased
slightly over time in each of the groups (Figure 4a). Pre-
scription of ≤4 SABA canisters per year increased in all
groups over time (Figure 4b). Prescription of ≥13 SABA
canisters per year decreased in all groups over time
(Figure 4c). Primary care and emergency department visits
for asthma decreased over time among each of the groups
(Figures 5 and 6). Primary care visits were highest in all
years for patients in the fee-for-service group, and lowest
in the blended capitation group (Figure 5). Emergency de-
partment visits were lowest in all years in the blended fee-
for-service group (Figure 6).
Asthma performance adjusted for potential confounders
As seen in Figure 7, compared to the fee-for-service
model, the blended fee-for-service model had higher
rates of spirometry use for diagnosis (adjusted risk ratio
[RR] = 1.14), spirometry use for monitoring (RR = 1.07),
ICS prescriptions (RR = 1.05), and lower rates of SABA
prescription (RR = 0.97). In terms of outcome indicators,
Table 2 Overall percent distributions of asthma indicators, 2006 to 2010
2006 2007 2008 2009 2010 2006 to 2010
Asthma indicators % 95% CI % 95% CI % 95% CI % 95% CI % 95% CI % change 95% CI p-value
for trend
Process-related indicators
Use of spirometry
To diagnose asthma 46.8 (46.2, 47.5) 48.8 (48.1, 49.5) 49.9 (49.2, 50.7) 51.0 (50.3, 51.8) 52.5 (51.6, 53.5) 12.2 (10.3, 14.0) <0.001
To monitor asthma 16.4 (16.2, 16.5) 17.0 (16.9, 17.2) 17.2 (17.1, 17.4) 17.7 (17.6, 17.9) 19.1 (18.9, 19.2) 16.5 (15.2, 17.8) <0.001
Asthma medication prescriptions (in patients ≥65 years old)
Inhaled corticosteroids 72.9 (72.1, 73.7) 74.2 (73.3, 75.0) 74.7 (73.8, 75.5) 75.2 (74.4, 76.1) 76.6 (75.8, 77.5) 5.1 (4.3, 6.0) <0.001
Short acting β2-agonist 60.5 (59.7, 61.2) 60.7 (59.9, 61.4) 58.2 (57.4, 58.9) 57.8 (57.0, 58.5) 58.5 (57.8, 59.3) −3.3 (−4.3, −2.1) <0.001
≤4 canisters per year 56.6 (55.7, 57.6) 57.7 (56.7, 58.6) 60.5 (59.5, 61.5) 61.2 (60.2, 62.3) 61.6 (60.6, 62.7) 8.8 (7.3, 10.5) <.0001
5-12 canisters per year 30.3 (29.6, 31.0) 30.4 (29.7, 31.1) 29.3 (28.6, 30.0) 29.0 (28.3, 29.7) 29.4 (28.7, 30.1) −3.0 (−5.5, −0.2) 0.0008
13-20 canisters per year 8.7 (8.3, 9.1) 8.2 (7.9, 8.6) 7.3 (7.0, 7.7) 7.1 (6.8, 7.5) 6.5 (6.2, 6.9) −25.3 (−29.4, −20.0) <.0001
>20 canisters per year 4.4 (4.1, 4.6) 3.7 (3.5, 4.0) 2.9 (2.7, 3.1) 2.7 (2.5, 2.9) 2.4 (2.2, 2.6) −45.5 (−50.5, −39.5) <.0001
Outcome-related indicators
Asthma specific health services use
Primary care visits 20.8 (20.8, 20.9) 20.0 (19.9, 20.1) 18.4 (18.3, 18.5) 17.5 (17.4, 17.5) 17.1 (17.0, 17.1) −17.8 (−18.4, −17.7) <0.001
Emergency department visits 2.4 (2.4, 2.4) 2.2 (2.2, 2.2) 1.9 (1.9, 1.9) 1.8 (1.8, 1.8) 1.7 (1.7, 1.7) −29.2 (−30.0, −27.9) <0.001
Other health services use
Primary care visits 86.2 (86.1, 86.4) 84.9 (84.8, 85.0) 83.4 (83.3, 83.6) 83.8 (83.7, 83.9) 83.1 (83.0, 83.2) −3.6 (−3.9, 3.4) <0.0001
Emergency department visits 26.1 (26.0, 26.1) 25.9 (25.9, 26.0) 25.8 (25.7, 25.8) 25.7 (25.6, 25.8) 25.9 (25.8, 26.0) −0.8 (−1.1, 0.0) <0.0001
Note: p-value is based on the Cochran-Armitage test for trend for multiple proportions.
To
et
al.BM
C
Fam
ily
Practice
 (2015) 16:19 
Page
6
of
12
30
40
50
60
70
80
90
2006 2007 2008 2009 2010
%
 o
f 
ca
se
s 
7 
ye
ar
s 
o
r 
o
ld
er
 w
h
er
e 
sp
ir
o
m
et
ry
 w
as
 u
se
d
 f
o
r 
d
ia
g
n
o
si
s
Year
Overall
Fee-for-service
Blended fee-for-service
Blended capitation
Figure 1 Spirometry used to establish diagnosis of asthma. Note: Spirometry was performed on those ≥7 years of age within 3.5 years of
the diagnosis date.
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(RR = 0.92) and slightly lower rates of outpatient claims
(RR = 0.97).
Compared to fee-for-service models, the blended
capitation model also had higher rates of spirometry
use for diagnosis (RR = 1.25), spirometry for monitor-
ing (RR = 1.17), and ICS prescriptions (RR = 1.08).
Their rate of SABA prescription did not differ from the
fee-for-service model. In terms of outcome indicators,
their rate of outpatient claims (RR = 0.82) are much
lower than both the fee-for-service and blended fee-for-
service models, but their patients’ rates of emergency
department visits (RR = 1.08) were higher than both
the fee-for-service and blended fee-for-service models.
Discussion
Overall, quality of asthma care, as represented by per-
formance indicators, has improved over time. In general,
patient enrolment models (i.e., blended fee-for-service0
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Figure 2 Spirometry used to monitor asthma. Note: Spirometry testingand blended capitation models) appear to provide higher
quality of asthma care compared to traditional fee-for-
service models based on the analysis of asthma perform-
ance indicators. The blended-fee-for service group stood
out from both the fee-for-service and blended capitation
in terms of outcome indicators, namely by having a
lower rate of emergency department visits.
While the blended capitation model had higher rates
of use of spirometry for diagnosis and monitoring, and
higher rates of ICS prescriptions, they had lower rates of
outpatient visits and higher rates of emergency depart-
ment visits. These findings may be related to the fact
that the blended capitation model had more patients liv-
ing in rural areas. However, these results stood out even
after adjusting for patient characteristics. Thus, we can
suggest other factors that may have played a role, such
as co-morbidities, poor compliance to medication, lim-
ited access to primary care because of geographic loca-
tion or office hours, poor availability of after-hours2010
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Figure 3 Inhaled corticosteroid use in the past 12 months for asthma patients >65 years of age. Note: ICS = inhaled corticosteroids.
To et al. BMC Family Practice  (2015) 16:19 Page 8 of 12medical assistance, patient education, or limitations of
the process indicators to measure all variables involved
with quality of care.
Recent studies in Ontario have also shown quality of
care to be affected by primary care delivery models.
Glazier et al. also observed that patients followed by
physicians paid by the blended capitation model had
higher than expected emergency department visits than
fee-for-service physicians, whereas the patients in the
salaried model were sicker but had substantially lowera
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Figure 4 Short-acting β2-agonist use. a. Short-acting β2-agonist use in th
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12 months for asthma patients >65 years of ageemergency department visit rates than expected [20].
The study by Glazier et al. showed that different primary
care models served different patient populations, with
non-salaried health centre physicians caring for more
advantaged populations, and salaried physicians caring
for more disadvantaged populations. These data suggest
that pay structure may not be the only reason for differ-
ences in quality of care – individual patient characteris-
tics not measured with administrative data, specific
geographical location and practice infrastructure mayb
c
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Figure 5 The rate of primary care visit claims for asthma in the past 12 months. Note: OHIP = Ontario Health Insurance Plan.
To et al. BMC Family Practice  (2015) 16:19 Page 9 of 12partially explain the observed differences. Further, the
use of performance indicators may be influenced by fi-
nancial incentives within the different models.
These findings are relevant on an international level,
where there is a trend towards payment tied to perform-
ance and bundled primary care systems. In the United
Kingdom, primary care has moved towards group-based
practices with pay-for-performance compensation, in
which performance is measured using a number of quality
indicators [21]. In the United States, where compensation
is predominantly fee-for-service, policy recommendations
have suggested a shift towards more bundled payment sys-
tems, in which payment is also tied to performance [22].
Despite an overall increase in quality of asthma care
over time, there remains much room for improvement.
National guidelines recommend that all asthma cases
should be diagnosed using spirometry (in individuals old
enough to reliably perform spirometry); however, our
findings show that only half of patients with asthma had
their asthma diagnosed using spirometry. Furthermore,0
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Figure 6 The rate of emergency department visits for asthma in the pguidelines describe the necessity of regular monitoring
of asthma using spirometry, yet less than one-fifth of pa-
tients in our study underwent spirometry in the past
year.
A few limitations of this study should be noted. The
health administrative data definition of asthma may be
subject to potential misclassification when compared to
clinical evaluation by a physician, compounded by the
fact that physicians do not always accurately diagnose
asthma. When physicians submit claims, they enter an
asthma diagnostic code. This is often based on patient
symptoms, such as wheeze and cough, and can be sub-
ject to error. Further, as a large number of individuals
were older than 65 years of age, it is possible that they
had COPD in addition to asthma, or that the symptoms
they were presenting with were those of COPD, thus
there is the potential for misclassification or type 2 error.
While some studies have shown asthma to be overdiag-
nosed by physicians, others have shown it to be under-
diagnosed; it is therefore not clear how such possible2010
Overall
Fee-for-service
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ast 12 months. Note: ED = emergency department.
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Figure 7 Adjusted risk ratios of asthma performance indicators comparing primary care practices using fee-for-service practices as a
reference. Note: API=asthma performance indicator. *Performed on those ≥7 years of age, †ICS = inhaled corticosteroids (data only available for
persons ≥65 years of age and others eligible for the Ontario Drug Benefits Program), ‡Short-acting β2-agonist data only available for persons ≥65
years of age and others eligible for the Ontario Drug Benefits Program, §ED = emergency department. Green triangle = blended fee-for-service
practices. Blue circles = blended capitation practices.
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search comparing asthma health administrative and survey
data and found that, while there were differences in abso-
lute values, health administrative data were consistent
over time and therefore reliable for studying trends [26].
As suggested by Devlin and Sarma [27], physicians may
self-select into different primary care models based on per-
sonal preferences and unobserved characteristics leading
to potential selection bias. We included physician charac-
teristics in our regression analysis to help reduce, though
not eliminate, selection bias. In future, formal approaches
such as propensity score matching used by Kantarevic
et al. [28] or the difference-in-difference matching strategy
employed by Kantarevic et al. [29] and Li et al. [30] should
be considered to control for potential selection bias
through the inclusion of physician individual fixed effects.
We were unable to include indicators for the entire
population for analysis (e.g., prescription drug data was
only available for individuals 65 years or older). Inaddition, data were available on dispensing practices but
not on whether participants adhered to taking the medica-
tion. Further, use of portable peak expiratory flow meters
as an objective measure of lung function to diagnose and
monitor asthma was not captured by administrative billing
data.
While this is not a randomized control trial, and we
cannot guarantee that patient and physician groups were
similar, we did adjust for many patient and physician
characteristics in our analyses. Further to the discussion
of differences between models, it cannot be determined
with certainty whether or not more frequent use of indi-
cators resulted in better patient outcomes.
Conclusions
Quality of asthma care has improved over time. Patient
enrolment models appear to provide higher quality of
asthma care processes compared to traditional fee-for-
service model. Future improvements in quality of
To et al. BMC Family Practice  (2015) 16:19 Page 11 of 12asthma care should focus on increasing the use of spir-
ometry for asthma diagnosis and monitoring. Future re-
search should continue to use administrative data to
track asthma indicators on a population level to provide
a foundation for continuous quality improvement in the
provision of asthma care, as well as examine the direct
relationship between use of asthma indicators and pa-
tient outcomes.
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